These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months.
    Author: Gordon BL, Yanagihara R.
    Journal: Ann Allergy; 1977 Oct; 39(4):227-36. PubMed ID: 71868.
    Abstract:
    Treatment of 16 SLE patients with levamisole resulted in significant reduction of a variety of clinical parameters of the disease. Clinical improvement was both subjective and objective. Thus, levamisole may represent a possible alternative or adjunctive approach to SLE therapy. Although proper assessment of its actual quantitative importance in the treatment of Lupus must await large scale studies under double-blind conditions, nevertheless, these preliminary results are very encouraging.
    [Abstract] [Full Text] [Related] [New Search]